We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients...
Reported revenues of $6.5 million in 1Q24, up 116% compared to 1Q23 Reported gross margin of 85% in 1Q24 Secured up to $50 million of debt financing with OrbiMed to support TriNav® Infusion...
– Accomplished industry veteran brings deep strategic and operational expertise TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with...
Call Scheduled for Wednesday, May 15, 2024, at 9:00 a.m. ET TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to...
$25 million funded at close; up to $25 million of additional capital available at the Company’s option, based on the achievement of certain revenue thresholds Capital from the transaction is...
Reported revenues of $5.7 million in 4Q23, up 77% over prior year Full year revenues of $18.5 million, up 49% over prior year Gross Margin of 90% in 4Q23 and 86% for full year CMS reimbursement...
– New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic cancer supports further development of the novel TriSalus Infusion System for therapeutic delivery...
TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.62 | -7.96915167095 | 7.78 | 7.9 | 7.095 | 56550 | 7.61446437 | CS |
4 | -2.46 | -25.5717255717 | 9.62 | 10.24 | 6.8 | 40748 | 8.13106306 | CS |
12 | -2.83 | -28.3283283283 | 9.99 | 10.42 | 6.8 | 49852 | 9.17176614 | CS |
26 | 2.98 | 71.2918660287 | 4.18 | 10.42 | 3.61 | 59788 | 8.31983558 | CS |
52 | -6.64 | -48.115942029 | 13.8 | 16.24 | 3.32 | 53000 | 7.54007884 | CS |
156 | -6.64 | -48.115942029 | 13.8 | 16.24 | 3.32 | 53000 | 7.54007884 | CS |
260 | -6.64 | -48.115942029 | 13.8 | 16.24 | 3.32 | 53000 | 7.54007884 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions